Ibn Al-Haytham Pharma. Co. Launches Its 1st Pulmonology Scientific Meeting

Ibn Al-Haytham Pharma. Co. Launches Its 1st Pulmonology Scientific Meeting

In a step that reaffirms our ongoing commitment to leading the pharmaceutical sector and advancing respiratory care, Ibn Al-Haytham Pharmaceutical Industries launched its First Scientific Meeting for Pulmonologists, titled:

COPD & Asthma Management: From Guideline to Practice

Event Highlights

  • Opening Remarks: The meeting was opened by Dr. Mayada Habib, Marketing Manager at Ibn Al-Haytham.

  • Keynote Lecture: A specialized lecture was delivered by Dr. Mazen Qussaibati, focusing on the use of inhalers in managing Chronic Obstructive Pulmonary Disease (COPD).

  • Corporate Presentation: Dr. Khaled Alwan, Product Manager in the Marketing Department, delivered a presentation highlighting Ibn Al-Haytham’s pioneering role in providing respiratory care.

Collaboration for Better Patient Outcomes

The event witnessed an outstanding attendance of elite pulmonologists from various Syrian governorates. Discussions centered around the daily challenges physicians face in managing asthma and COPD patients, while shedding light on how to efficiently apply global guidelines to daily clinical practice.

At Ibn Al-Haytham, we believe that providing advanced therapeutic solutions always goes hand-in-hand with supporting continuous scientific dialogue. This aligns with our vision of delivering exceptional respiratory care that puts the patient's quality of life first.

We extend our deepest gratitude and appreciation to all participating physicians and to everyone who contributed to the success of this distinguished scientific meeting.